Tenon Medical Incの最新の1株当たり利益は$-0.38で、$-0.36の予想を打ちつける。
Tenon Medical Inc TNONの前四半期の収益はどうでしたか?
Tenon Medical Incの前四半期の収益は$-0.38です。
Tenon Medical Incの収益見積もりはいくらですか?
4人のウォール街のアナリストによると、Tenon Medical Incの収益見積もりは$1.73Mから$1.35Mの範囲です。
Tenon Medical Incの収益品質スコアはどれくらいですか?
Tenon Medical Incの収益品質スコアはB+/48.753952です。このスコアは、収益性、成長、キャッシュ生成と資本配分、レバレッジの4つの次元に基づいています。
Tenon Medical Incはいつ収益を報告しますか?
Tenon Medical Incの次の収益報告は2026-06-17に予定されています
Tenon Medical Incの予想収益はいくらですか?
ウォール街のアナリストによると、Tenon Medical Incの予想収益は$1.4Mです。
Tenon Medical Incは収益予想を上回りましたか?
Tenon Medical Incの最近の収益は$1.48Mで、予想をビート。
主要データ
前終値
$0.7256
始値
$0.713
当日レンジ
$0.7032 - $0.737
52週レンジ
$0.641 - $2.48
取引高
81.2K
平均取引高
1.0M
配当利回り
--
1株当たり利益(TTM)
-2.76
時価総額
$7.7M
TNONとは何ですか?
Tenon Medical, Inc. is a medical device company, which engages in the development of a minimally invasive approach to the sacroiliac joint (SI joint) using a single titanium implant for treatment of the most common types of SI Joint disorders. The company is headquartered in Los Gatos, California and currently employs 27 full-time employees. The company went IPO on 2022-04-27. The firm has developed the Catamaran SI Joint Fusion System that offers a novel, less invasive approach to the SI joint using a single, robust titanium implant. The system features the Catamaran Fixation Device which passes through both the axial and sagittal planes of the ilium and sacrum, stabilizing and transfixing the SI Joint along its longitudinal axis. The angle and trajectory of the Catamaran surgical approach is also designed to provide a pathway away from critical neural and vascular structures and into the strongest cortical bone. Its trademarks include Catamaran, PiSIF, CAT PiSIF, ETAD, CAT SIJ Fusion System, SImmetry, MAINSAIL, SImmetry+, Catamaran Transfixation Fusion Device, Catamaran Transfixation Fusion System, and others. The Catamaran SI Joint Fusion System offers a novel, less invasive Inferior-Posterior approach to the SI joint using a single, robust titanium implant.